These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2953799)

  • 1. Cutaneous mast cell depletion and recovery in murine graft-vs-host disease.
    Choi KL; Giorno R; Claman HN
    J Immunol; 1987 Jun; 138(12):4093-101. PubMed ID: 2953799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells".
    Claman HN; Choi KL; Sujansky W; Vatter AE
    J Immunol; 1986 Sep; 137(6):2009-13. PubMed ID: 3745920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous in situ detection of IgE receptors and cytoplasmic granules in murine cutaneous mast cells.
    Giorno R; Choi KL; Claman HN
    J Immunol Methods; 1987 May; 99(2):163-6. PubMed ID: 2953820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of stem cell factor on the ultrastructure of Fc epsilon RI+ cells developing in IL-3-dependent murine bone marrow-derived cell cultures.
    Rottem M; Goff JP; Albert JP; Metcalfe DD
    J Immunol; 1993 Nov; 151(9):4950-63. PubMed ID: 7691960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histochemical and ultrastructural studies of mast cells in the intestinal mucosa and skin of the opossum Didelphis albiventris.
    Santos AA; Machado CR
    Histochem J; 1994 Mar; 26(3):233-8. PubMed ID: 7515867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cellular dermal infiltrates in human cutaneous mastocytosis.
    Mirowski G; Austen KF; Chiang L; Horan RF; Sheffer AL; Weidner N; Murphy GF
    Lab Invest; 1990 Jul; 63(1):52-62. PubMed ID: 2374400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen-binding factor.
    Kops SK; Van Loveren H; Rosenstein RW; Ptak W; Askenase PW
    Lab Invest; 1984 Apr; 50(4):421-34. PubMed ID: 6608629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
    Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A
    Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell depletion in murine chronic graft-versus-host disease.
    Claman HN
    J Invest Dermatol; 1985 Apr; 84(4):246-8. PubMed ID: 3981034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine KIT+ lineage- bone marrow progenitors express Fc gamma-RII but do not express Fc epsilon-RI until mast cell granule formation.
    Lantz CS; Huff TF
    J Immunol; 1995 Jan; 154(1):355-62. PubMed ID: 7527815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide analogs that inhibit IgE-Fc epsilon RI alpha interactions ameliorate the development of lethal graft-versus-host disease.
    Korngold R; Jameson BA; McDonnell JM; Leighton C; Sutton BJ; Gould HJ; Murphy GF
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):187-93. PubMed ID: 9360780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease.
    Levi-Schaffer F; Goldenhersh MA; Segal V; Nagler A
    Bone Marrow Transplant; 1997 Apr; 19(8):823-8. PubMed ID: 9134176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cells containing IgE in the intestinal mucosa of mice infected with the nematode parasite Trichinella spiralis are predominantly of a mast cell lineage.
    Alizadeh H; Urban JF; Katona IM; Finkelman FD
    J Immunol; 1986 Oct; 137(8):2555-60. PubMed ID: 3531336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells induced in vitro by interleukin 3 from native murine thymus cells.
    Kawanishi H; Medicus RG; Palaszynski EW
    Scand J Immunol; 1986 Jul; 24(1):29-38. PubMed ID: 2425414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells in murine graft-versus-host disease: a model of immunologically induced fibrosis.
    Choi KL; Claman HN
    Immunol Ser; 1989; 46():641-51. PubMed ID: 2488873
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis.
    Claman HN; Jaffee BD; Huff JC; Clark RA
    Cell Immunol; 1985 Aug; 94(1):73-84. PubMed ID: 4016962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man.
    Janin-Mercier A; Devergie A; Van Cauwenberge D; Saurat JH; Bourges M; Lapiere CM; Gluckman E
    Am J Pathol; 1984 May; 115(2):296-306. PubMed ID: 6372497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-phase pathogenesis of graft-versus-host disease in mice.
    van Leeuwen L; Guiffre A; Atkinson K; Rainer SP; Sewell WA
    Bone Marrow Transplant; 2002 Jan; 29(2):151-8. PubMed ID: 11850710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell fixation and staining in image analysis.
    Bianchi S; Mugnai L
    Eur J Basic Appl Histochem; 1991; 35(2):161-74. PubMed ID: 1722708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.